Arvelle Therapeutics was acquired by Angelini Pharma
Zählerweg 6, 6300 Zug, Switzerland
Revolutionizing clinical trials, Trialize's cutting-edge automation platform accelerates study build times by 4x and curbs manual labor by up to 73%, enhancing data quality, patient adherence, and team morale. It's a game-changer in modern, decentralized, and virtual studies.
